强制降解 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-08 and is reviewed periodically as new material appears.
Peptides are sensitive to temperature, light, oxygen, and repeated freeze-thaw cycles. Semaglutide in dry form is generally held at refrigerated temperatures, while reconstituted solutions require a defined short-term storage window. Vials should be kept in secondary packaging to limit photodegradation, and exposure to alkaline conditions is avoided because it accelerates chemical degradation. Adsorption to glass and some plastics can reduce the measured concentration of dilute solutions, so low-binding polypropylene containers are preferred for analytical work. Each transfer step introduces a small risk of contamination, and closed handling practices reduce that risk.
Routine characterisation of the peptide relies on reversed-phase high-performance liquid chromatography, often paired with ultraviolet detection near 214 nanometres. Related substances such as deamidated, oxidised, and truncated sequences elute at characteristic positions and are quantified by area percentage. Electrospray ionisation mass spectrometry confirms the molecular mass and can resolve some closely related variants. Peptide mapping after enzymatic digestion provides sequence-level verification and is useful when a full identity profile is required. Method parameters such as column chemistry, gradient, and mobile-phase pH influence the separation and must be reported alongside results.
Storage conditions for semaglutide depend heavily on the presentation. Lyophilized research powder is generally kept at two to eight degrees Celsius in a sealed container, protected from light and moisture. Manufacturer labeling for finished injectable products specifies refrigeration before first use, with defined in-use periods at room temperature afterward. The oral tablet form is stored at controlled room temperature and is more tolerant of short excursions. Temperature excursions should be documented rather than inferred.
Peptide degradation follows several routes. Hydrolysis cleaves the backbone at susceptible residues, oxidation targets methionine and tryptophan side chains, and aggregation produces higher-molecular-weight species that are difficult to reverse. Light exposure accelerates oxidation, which is why amber glass or opaque secondary packaging is common. Repeated freeze-thaw cycles promote aggregation and are best avoided. Stability-indicating methods detect these changes before they become visible.
Quality control for research material typically involves reversed-phase HPLC for purity and identity, mass spectrometry for molecular weight confirmation, and Karl Fischer titration for residual water content. Peptide content is often reported as the mass of actual peptide rather than total powder mass, since counterions and water contribute to the latter. A certificate of analysis should list the method used for each specification. Limits and acceptance criteria vary by supplier and by intended application.
| Property | Value | Notes |
|---|---|---|
| Typical purity threshold | 95 percent or greater by HPLC area | common specification for research-grade peptide |
| Primary separation method | Reversed-phase HPLC | resolves related peptides and oxidation products |
| Identity confirmation | Electrospray mass spectrometry | observed mass compared with theoretical mass |
| Common degradation products | Deamidated and oxidised variants | form during synthesis and during storage |
| Preferred container | Low-binding polypropylene | reduces adsorption of dilute solutions |
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
关于降解产物的免疫原性风险，文献中仍有讨论空间。体外聚集水平与临床免疫反应之间的定量关系尚未确立。多数公开研究只报告理化指标，缺少长期随访的对应数据。这一问题在生物类似物比对中尤其受到关注。
市售注射用制剂通常要求在二至八摄氏度冷藏保存，并避免光照与冻结。部分多剂量笔在首次使用后允许在不超过三十摄氏度的环境中存放有限周数，具体期限由辅料与防腐剂体系决定。反复冻融会促进肽链聚集并改变可见颗粒计数，因此应予避免。冻干粉末在干燥、避光、低温条件下更为稳定。溶液配制后宜使用低吸附容器，以减少肽类在塑料或玻璃表面的损失。
纯度评价多采用反相高效液相色谱，流动相常加入三氟乙酸或甲酸作为离子对改性剂，检测波长设在二百一十四纳米或二百二十纳米。分子量确认依靠电喷雾电离质谱或基质辅助激光解吸电离质谱，实测值应与理论值在数 ppm 内吻合。肽图分析通过酶切后液相色谱串联质谱完成，用于核查序列与修饰位点。体积排阻色谱用于定量共价与非共价聚集体。生物基质浓度测定则采用免疫分析或液相色谱串联质谱。
== Etymology == While exploring inland along the northern coast of Florida in 1528, the members of the Narváez expedition, including Álvar Núñez Cabeza de Vaca, found a Native American village near present-day Tallahassee, Florida, the name of which they transcribed as Apalchen or Apalachen (Apalachee pronunciation: [a.paˈla.tʃɛn]). The name was soon altered by the Spanish to Apalachee and used as a name for the tribe and region spreading well inland to the north. Pánfilo de Narváez's expedition first entered Apalachee territory on June 15, 1528, and applied the name. Now spelled "Appalachian", it is the fourth-oldest surviving European place-name in the US. After the 1540 expedition of Hernando de Soto, Spanish cartographers began to apply the name of the tribe to the mountains themselves. The first cartographic appearance of Apalchen is on Diego Gutiérrez's map of 1562; the first use for the mountain range is the map of Jacques le Moyne de Morgues in 1565.
=== Correlation with birth defects === Some studies show a correlation between the consumption of potatoes suffering from late blight (which increases solanine and other glycoalkaloid levels) and the incidence of spina bifida in humans. However, other studies have shown no correlation between potato consumption and the incidence of birth defects.
One example of a paper-based microfluidic device utilizing electrochemical detection has a dumbbell shape to isolate plasma from whole blood. The current from the hydrogen peroxide produced in the aforementioned catalytic cycle is measured and converted into concentration of glucose.
Moore and another Liverpool biochemist, Edward Whitney, founded the Biochemical Journal in 1906, one year after the creation of the US-based Journal of Biological Chemistry in 1905. Both journals still exist. Moore served as the first Biochemical Journal editor with the journal initially being published by the Liverpool University Press, the 3rd oldest University Press in England. Moore was concerned with the high mortality for the United Kingdom of pulmonary tuberculosis (TB), which he called the ‘Great White Plague', concluding that with 'the foundation of a new National Health Service and the provision of segregation for infectious cases in sanatoria, the disease could be eradicated'. Other holders of the Johnston Chair include RA Morton, FRS HH Rees, the late Trevour Goodwin FRS and the current Head of Department PA Eyers The Liverpool-originated Biochemical Journal was acquired by the London-based Biochemical Club (later renamed the Biochemical Society in 1911.
Sources: en.wikipedia.org
For services to Public Health in Scotland. Gerard Anthony Lemos, CMG. Non-Executive Chair, HM Prisons and Probation Service Agency Board. For Public and Voluntary Service. Zoe Ann Lewis. Principal and Chief Executive Officer, Middlesbrough College. For services to Further Education. Dr. Andrew John Mackintosh. Adviser, The Knowledge Assets Initiative. For services to Science and Technology, and to Enterprise Development. Barbara Hilary Manning. Lately Head of Payments, Banking and Shared Services, Department for Work and Pensions. For services to the Public and to the State Funeral of Her Majesty Queen Elizabeth II. Anthony McGee. Director, Ukraine Task Force, Ministry of Defence. For Public Service. Michael Messinger, LVO, QPM. Lately Chancellor, Order of St. John (England) and Deputy Chairman, St John Ambulance. For voluntary service to St John Ambulance. Colin Morrison, OBE. Founder and Chair, Boarding School Partnerships. For services to Education. Katherine Louise Mosse, OBE. Author. For services to Literature, to Women and to Charity. Ciaran Michael Murphy, KC. Senior Counsel. For services to Criminal Justice. Stuart Neil Luke Murphy. Chief Executive, English National Opera. For services to Opera. Professor Joseph Gerard Nellis. Professor of Global Economy, School of Management Cranfield University. For services to Higher Education, to Economics, to Business and to Charity. Dr. Vanessa Jane Ogden. Chief Executive Officer, Mulberry Schools Trust. For services to Education. René Olivieri. For services to the Charitable Sector. Lynn Margaret Pamment.
== History == Scientists in Japan began to collaborate as early as 1939 on the development of an electron microscope. Kenji Kazato and Kazuo Ito met while working at the Naval Central Institute in Tokyo during World War II. After the war, Kazato attracted Ito and a group of others to Mobara, Chiba Prefecture, Japan. This initial group developed a prototype magnetic field–type electron microscope called the DA-1, which was sold to Mitsubishi in 1947. Because of differences over the direction of this early company, Kazato and Ito chose to found a new organization. The Japan Electron Optics Laboratory Company, Limited (Nihon Denshi Kogaku Kenkyujo) was founded in 1949 by Kenji Kazato and Kazuo Ito in Mitaka, Tokyo. It produced its first commercial model transmission electron microscope, the JEM-1, a year later. Overseas sales began in 1956 with the sale of a system to France. The company's strengths were the customization of orders to fit customer requests, and the provision of strong customer support. In 1961, the company was renamed JEOL, Limited. Its first overseas subsidiary, JEOL Company (USA) Inc., was established in 1962 and headquartered in Peabody, MA. JEOL was listed on the Second Section of the Tokyo Stock Exchange by 1962, and on the First Section of the Tokyo Stock Exchange by 1966. The company expanded from electron microscopy to nuclear magnetic resonance (NMR), releasing the first NMR system in Japan, the JNM-1, in 1956. They produced their first mass spectrometer in 1963, and their first scanning electron microscope in 1966.
A pariah field, cast out by the scientific establishment. Between cold fusion and respectable science there is virtually no communication at all. Cold fusion papers are almost never published in refereed scientific journals, with the result that those works don't receive the normal critical scrutiny that science requires. On the other hand, because the Cold-Fusioners see themselves as a community under siege, there is little internal criticism. Experiments and theories tend to be accepted at face value, for fear of providing even more fuel for external critics, if anyone outside the group was bothering to listen. In these circumstances, crackpots flourish, making matters worse for those who believe that there is serious science going on here.
=== Distributor's losses and impact === Though Darbar became the highest-grossing Tamil film of 2020, grossing ₹202–250, several distributors claimed that they incurred significant financial losses due to the film’s high acquisition costs and pre-release rights pricing. Trade analysts estimated that distributors collectively suffered losses of around ₹70 crore. It did not perform well in other Indian states, including Andhra Pradesh and Telangana, due to competition from Ala Vaikunthapurramuloo and Sarileru Neekevvaru, and the Hindi version was unsuccessful at the box office due to a lack of promotion. Following unsuccessful discussions with Lyca Productions, a group of distributors attempted to approach Rajinikanth seeking financial relief. Media reports stated that some distributors threatened protests, including hunger strikes, if their concerns were not addressed. Industry commentators later compared the situation to earlier Rajinikanth films such as Baba (2002), Kuselan (2008) and Lingaa (2014). Trade publications attributed the dispute primarily to the film’s high production and acquisition costs. Reports indicated that Rajinikanth and director A. R. Murugadoss received substantial remuneration, contributing to an increased production budget, while the film’s distribution rights were sold at premium rates. Some commentators cited the episode as part of a broader industry debate on the financial risks associated with high-budget star-driven films.
=== Neuromyotonia === Neuromyotonia refers to muscle twitching and cramping at rest that is exacerbated with exercise. It is caused by sustained or repetitive spontaneous muscle activity of peripheral nerve origin. Myokymia, or spontaneous rippling and twitching movements of muscles, is a visible component of neuromyotonia. Electromyography (EMG) discloses spontaneous, repetitive motor unit or single fiber discharges firing in irregular rhythmic bursts at high intraburst frequencies. Some of the muscles exhibiting twitching include the bilateral gastrocnemii, quadriceps femoris, biceps brachii, and right masseter. In vivo electrophysiological studies suggest at least some dysfunction of the muscle cell membrane. In the examined muscles, no abnormal insertional activity or fibrillation potentials were noted. Nerve conduction studies were normal.
Sources: en.wikipedia.org
== Multiple collector inductively coupled plasma mass spectrometry == An MC-ICP-MS instrument is a multiple collector mass spectrometer with a plasma source. MC-ICP-MS was developed to improve the precision achievable by ICP-MS during isotope-ratio measurements. Conventional ICP-MS analysis uses a quadrupole analyser, which only allows single-collector analysis. Due to the inherent instability of the plasma, this limits the precision of ICP-MS with a quadrupole analyzer to around 1%, which is insufficient for most radiogenic isotope systems. Isotope-ratio analysis for radiometric dating has normally been determined by TIMS. However, some systems (e.g. Hf-W and Lu-Hf) are difficult or impossible to analyse by TIMS, due to the high ionization potential of the elements involved. Therefore, these methods can now be analysed using MC-ICP-MS. The Ar-ICP produces an ion-beam with a large inherent kinetic energy distribution, which makes the design of the mass-spectrometer somewhat more complex than it is the case for conventional TIMS instruments. First, different from Quadrupole ICP-MS systems, magnetic sector instruments have to operate with a higher acceleration potential (several 1000 V) in order to minimize the energy distribution of the ion beam. Modern instruments operate at 6-10kV. The radius of deflection of an ion within a magnetic field depends on the kinetic energy and the mass/charge ratio of the ion (strictly, the magnet is a momentum analyzer not just a mass analyzer).
Most refrigerator-freezers—except for manual defrost models or cheaper units—use what appears to be two thermostats. Only the refrigerator compartment is properly temperature controlled. When the refrigerator gets too warm, the thermostat starts the cooling process and a fan circulates the air around the freezer. During this time, the refrigerator also gets colder. The freezer control knob only controls the amount of air that flows into the refrigerator via a damper system. Changing the refrigerator temperature will inadvertently change the freezer temperature in the opposite direction. Changing the freezer temperature will have no effect on the refrigerator temperature. The freezer control may also be adjusted to compensate for any refrigerator adjustment. This means the refrigerator may become too warm. However, because only enough air is diverted to the refrigerator compartment, the freezer usually re-acquires the set temperature quickly, unless the door is opened. When a door is opened, either in the refrigerator or the freezer, the fan in some units stops immediately to prevent excessive frost build up on the freezer's evaporator coil, because this coil is cooling two areas. When the freezer reaches temperature, the unit cycles off, no matter what the refrigerator temperature is. Modern computerized refrigerators do not use the damper system. The computer manages fan speed for both compartments, although air is still blown from the freezer.
In 2003–04, SOCPAC supported the AFP by training a larger number of Filipino forces. Again, 1st SFG deployed two successive force packages, consisting of one ODB and 5 ODAs, to conduct Security Assistance during 2003, and a third force package in 2004 of one ODB and 3 ODAs. In total the ODAs trained 5 AFP army and one AFP marine battalions. During the same period, 1st Battalion of 1st SFG continued training the Filipino Counterterrorist force, preparing and outfitting an additional two Light Reaction Companies (LRCs). ODAs from 1st Battalion of 1st SFG also assisted in the design of a Joint Special Operations Group (JSOG), including AFP air force rotary wing lift assets. On 30 June 2004, a U.S. Special Forces soldier from 2nd Battalion, 1st SFG, was killed in a non-hostile incident in Manila. SOCPAC also introduced Operations/Intelligence Fusion Teams (O/IFTs) to work with various organizations in AFP's Southern Command. The O/IFTs provided advice and assistance on collection priorities and force employment at division and brigade. Beginning in 2004, 1st Battalion 1st SFG provided two ODAs continuously to serve as O/IFTs, both to the newly created JSOG and to Filipino 6th Infantry Division in Mindanao. In the summer of 2005, terrorists from the ASG and JI had moved from Mindanao to Sulu where they sought refuge.
== History == Following the discovery of iodine by Bernard Courtois in 1811, it has been broadly used for the prevention and treatment of skin infections, as well as the treatment of wounds. Iodine has been recognized as an effective broad-spectrum bactericide, and is also effective against yeasts, molds, fungi, viruses, and protozoans. Drawbacks to its use in the form of aqueous solutions include irritation at the site of application, toxicity, and the staining of surrounding tissues. These deficiencies were overcome by the discovery and use of PVP-I, in which the iodine is carried in a complexed form and the concentration of free iodine is very low. The product thus serves as an iodophor. PVP-I was discovered in 1955, at the Industrial Toxicology Laboratories in Philadelphia by H. A. Shelanski and M. V. Shelanski. They carried out tests in vitro to demonstrate anti-bacterial activity, and found that the complex was less toxic in mice than tincture of iodine. Human clinical trials showed the product to be superior to other iodine formulations.
Corn (maize) became a staple food in the southeast United States and in parts of Europe. A disease that was characterized by dermatitis of sunlight-exposed skin was described in Spain in 1735 by Gaspar Casal. He attributed the cause to poor diet. In northern Italy it was named "pellagra" from the Lombard language (agra = holly-like or serum-like; pell = skin). In time, the disease was more closely linked specifically to corn. In the US, Joseph Goldberger was assigned to study pellagra by the Surgeon General of the United States. His studies confirmed a corn-based diet as the culprit, but he did not identify the root cause. Nicotinic acid was extracted from liver by biochemist Conrad Elvehjem in 1937. He later identified the active ingredient, referring to it as "pellagra-preventing factor" and the "anti-blacktongue factor." It was also referred to as "vitamin PP", "vitamin P-P" and "PP-factor", all derived from the term "pellagra-preventive factor". In the late 1930s, studies by Tom Douglas Spies, Marion Blankenhorn, and Clark Cooper confirmed that nicotinic acid cured pellagra in humans. The prevalence of the disease was greatly reduced as a result. Nicotinic acid was initially synthesized by oxidizing nicotine with potassium chromate and sulfuric acid. Hence, in 1942, when flour enrichment with nicotinic acid began, a headline in the popular press said "Tobacco in Your Bread." In response, the Council on Foods and Nutrition of the American Medical Association approved of the Food and Nutrition Board's new names niacin and niacin amide for use primarily by non-scientists.
Sources: en.wikipedia.org
Different techniques detect different classes of impurities, so a single number does not describe a sample completely. Reversed-phase chromatography resolves related peptides well but can miss inorganic salts, while mass spectrometry confirms mass without quantifying everything present. Comparing results requires knowing which method was used and how it was validated.
Cycling between frozen and liquid states can promote aggregation and surface adsorption at the container wall. Each cycle exposes the peptide to transient concentration and pH shifts near the ice interface. Aliquoting before storage limits the number of cycles a single container experiences.
Purity describes how much of the material is the intended substance, while identity describes whether that substance is the correct molecule. Mass spectrometry gives an observed mass that is compared with the theoretical value for the sequence. Peptide mapping after digestion adds sequence-level confirmation that mass alone cannot provide.
Sealed, protected from light, and refrigerated at two to eight degrees Celsius for most research material. Desiccated storage limits moisture uptake. Allow the vial to reach room temperature before opening to prevent condensation.